En

What is Nexavir/Nexcream? | Uses, Benefits & Antiviral Properties

Introduction to Nexavir (Kutapressin)

NEXAVIR, previously known as Kutapressin, has been widely used since the 1930s, primarily for treating dermatological and viral infections. Nexavir is a non-toxic, non-allergic drug originally derived from fractionated liver paste or extract. It has unique properties that make it effective in treating various conditions.

Uses and Benefits of Nexavir

Nexavir functions as an anti-inflammatory agent, particularly for acute allergic reactions of the skin such as:

  • Severe contact dermatitis (e.g., Poison Ivy)
  • Shingles
  • Rosacea

Derived from porcine liver, Nexavir contains peptides that help modulate the immune response. Additionally, it constricts blood vessels, reducing swelling and improving conditions such as:

  • Keloids and papillomas
  • Acne vulgaris and acne rosacea
  • Rhinophyma (rosacea-related nose enlargement)
  • Pruritus ani (anal itching)

Case reports suggest Nexavir may relieve pain caused by vascular spasm diseases, including Raynaud’s disease and Buerger’s disease.

Antiviral Properties of Nexavir

Nexavir has demonstrated the ability to inhibit viral replication, particularly against:

  • Human herpesvirus-6 (HHV-6)
  • Epstein-Barr virus (EBV)

It is believed to work by preventing viruses from attaching to cellular receptors or inhibiting their maturation.

History and Evolution of Nexavir

Originally developed in the 1930s by Kremers-Urban Company in Milwaukee, Nexavir changed ownership over the years:

  • Acquired by Schwarz Pharma (Germany)
  • Acquired by Nexco Pharma in 2004 and renamed Nexavir

As a grandfathered drug, Nexavir predates FDA regulations, maintaining its non-toxic and non-allergic profile for over 80 years.

Nexavir for Chronic Fatigue Syndrome (CFS/ME)

In the 1960s, three physicians discovered Nexavir’s antiviral properties and successfully used it for Chronic Fatigue Syndrome/Myalgic Encephalopathy (CFS/ME) patients. It became a widely recognized treatment worldwide for CFS/ME and was found effective for:

  • MONO (Mononucleosis)
  • Epstein-Barr Virus (EBV)
  • HHV-6A, Hepatitis B (HBV), Hepatitis C (HCV)

Nexavir vs. Nexcream

Nexco Pharma has developed two products based on this formulation:

  • Nexavir Injectable – for systemic treatment
  • Nexcream – a topical cream/gel for dermatological applications

FAQ

Nexavir, formerly known as Kutapressin, is a non-toxic, non-allergic drug derived from porcine liver extract. It has anti-inflammatory and antiviral properties, making it effective for skin conditions, immune modulation, and viral infections like EBV and HHV-6.

Nexavir and Nexcream help treat:

  • Dermatological conditions (acne, rosacea, shingles, keloids)
  • Viral infections (EBV, HHV-6, Mono, Hepatitis B & C)
  • Chronic Fatigue Syndrome (CFS/ME)
  • Vascular disorders (Raynaud’s and Buerger’s disease)

Yes, Nexavir is non-toxic and non-allergic, with over 80 years of safe use. As a grandfathered drug, it has been used safely since before FDA regulations were established.

In the 1960s, doctors discovered Nexavir’s antiviral properties and used it successfully for CFS/ME patients. It helps by reducing viral replication, supporting immune function, and alleviating fatigue-related symptoms.

  • Nexavir Injectable: Used for systemic treatment of viral infections, immune conditions, and CFS/ME.
  • Nexcream: A topical gel/cream primarily for skin conditions like rosacea, acne, and dermatitis.